INTRODUCTION
It is a great privilege to give this, the third Herman Beerman Lecture, on "Transplantation: Past, Present and Future" in honor of a man to whom biologists and clinicians alike owe a great debt for his invaluable services to the cause of both experimental and investigative dermatology.
Probably no branch of medico-biological science has enjoyed such an explosive growth in practice and popularity, since the end of World War II, as that concerned with the transplantation of biological material at all anatomical levels of organization. The grafts may be single, discrete cells, such as tumor cells or fertilized ova; suspensions of cells such as blood or peritoneal exudates; solid tissues such as shin; completely functional organs such as ovaries, kidneys, lungs, or the liver; or, in the extreme case, entire individuaLs-f or surgical parabiosis involves graf ting the body of one individual onto that of another (1, 2) . Even non-viable grafts of some tissues, such as preserved bone and cartilage, are now fairly widely employed in replacement surgery (3, 4) .
Every medical school now seems to feel some obligation to have a "transplantation unit" if for no other reason than prestige. No conference on immunology is considered well oriented unless it includes at least one session on some aspect of transplantation immunity. Meetings specifically devoted to the subject, at both the national and international levels, have become so frequent as to cause concern whether they aren't now impeding progress, rather than facilitating it, by keeping investigators away from their laboratories, traveling or rewriting unnecessarily to * Member of the Wistar Institute of Anatomy and Biology and Professor of Zoology at the University of Pennsylvania. The Wistar Institute of Anatomy and Biology Philadelphia 4 , Pennsylvania.
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Even the daily newspapers and popular magazines, not to mention pharmaceutical house "Bulletins", reflect the grossly over-emphasized current popularity and competitive nature of the wide field now encompassed by the term "tissue transplantation".
This lecture represents an attempt to outline the origins, scope, and some of the achievements and possibilities of transplantation technics and to analyse, if possible, the basis of its current popularity.
Although the point is rarely stressed, there is a very special relationship between "tissue transplanters" and dermatologists. Not only does every act of transplantation necessarily involve damaging skin but, more important and for obvious reasons, skin is the tissue of choice for grafting purposes when the type of tissue to be transplanted is not a parameter of the experiment. Although close affinity between dermatology and surgery is admitted by neither profession, it is interesting that Sir Erasmus Wilson, President of the Royal College of Surgeons of England in 1881, is now recognized as having been an outstanding English dermatologist. According to an anonymous biographer (5) "to his teaching we owe in great measure the use of the bath, which has since become a conspicuous feature in the life of our upper and middle classes".
Apparently at the suggestion of Thomas Wakley, then editor of the Lancet, who advised him to "link himself so closely with skins that when he entered a room the company would scratch themselves", Wilson apparently foresook a successful career in anatomy and surgery in favor of dermatology.
HISTORICAL ORIGINS a) Skin Transplantation
It's quite certain that man was the first victim, or beneficiary, of tissue transplantation. Long before the birth of Christ, Hindu surgeons of the Tilemaker caste had evolved a technic for reconstructing an amputated nose by transposition of flaps of skin from the patient's forehead. There are grounds for believing that they could also employ free skin grafts for this purpose (6) .
The first fully documented experimental transplantation of free, full-thickness autografts of skin was carried out in a sheep, by a Milanese physiologist, Baronio (7), in 1804. He noted that hair was regenerated by these grafts and also made the important observation that separation of the tissue from the animal for an hour did not perceptibly prejudice its viability, thus hinting at the feasibility of tissue storage. Eighteen years later, in 1822, Bunger (8) of Marburg reported the successful employment of a free skin graft from a patient's thigh to reconstruct her nose.
It was Reverdin's (9) classic paper delivered in 1869, describing the use of tiny free skin autografts-usually referred to as "pinch" grafts-to promote the long-overdue epithelialization of extensive granulating wounds, which popularized skin transplantation as a clinical procedure.
A rather unrewarding diversion in the development of therapeutic skin grafting occurred at the latter end of the 19th century when "zoografting" was practiced fairly extensively (10) . This entailed heterotransplantation, i.e., transplantation of skin from alien donor species-e.g., from sheep, rabbits, pigs, and, most popular of all, from frogs,-to obstinate ulcers, burn lesions, etc. Zoografts seem to have been used with incredible enthusiasm. There is at least one detailed account on record of an attempt, made in 1880, to transplant flaps of skin from a lamb to a child. Gibson (10) , an authority of the history of zoografting, rightly questions what these early authors expected to happen to their grafts and what actually did happen to them.
Apparently, in these early days of free skin grafting, even in the case of autografts, no one really knew, or probably cared, whether the grafted tissue grew or not so long as complete epithelialization took place. Some authors, including Reverdin himself, actually believed that the grafts simply promoted a sort of epithelial "transformation" on the part of the granulation tissue. No one resorted to histology to settle the matter on account of a reluctance to compromise the fruits of their labors by removal of biopsy specimens. Although we now know that none of these heterografts could possibly have survived for more than a day or two at most, the possibility cannot be entirely discounted that, in some way or another, they did sometimes facilitate epithelialization. Rather surprisingly, as recently as 1957, the possible benefits of bovine embryonic skin as a temporary form of biologic dressing still attracted the attention of some investigators (11, 12) .
The early pioneers of human skin transplantation made no distinction between the behavior of grafts of a patient's own skin (i.e., autografts) and those derived from the bodies of other individuals (i.e., which we call homografts). George Lawson (13) , of London, undoubtedly voiced the naive opinion of his times when he predicted in 1870 that ". . . . the time will come when we shall beg portions of skin from a parent or friend who is willing to give of his abundance for the relief of a suffering child or of a neighbor". Little did he realize that in addition to public spirited generosity, fulfillment of this prediction requires the solution of a formidable biological obstacle which is still the central problem of transplantation research.
Following the popularization of plastic surgery, about 70 years were required before the widespread belief that skin from one individual would form a permanent graft on the body of another received its long overdue burial. This tenacious adherence to a fallacy occurred in the face of compelling evidence and declarations to the contrary by some of the early investigators such as Erich Lexer and Georg Schöne (see 14, 15 Studies on the transplantation of malignant tissues date back to 1889 when Hanau transferred a rat carcinoma from one rat to other members of this species. However, the real pioneer in this field was Jensen who found that spontaneous murine tumors could sometimes be propagated by transplantation from one mouse to another, and took pains to satisfy himself that what he was propagating was a lineage of cells and not some sort of infectious agent. In 1902 he reported on a tumor which he had passed through 19 generations by grafting and which grew in about 50% of inoculated subjects (15 and 17) . During the first decade of the present century it was clearly established by Jensen and others that the "race" of the host mice was important from the point of view of susceptibility to a tumor graft.
Extensive studies carried out during this period revealed that transplanted tumors either grew for a while, attaining palpable dimensions and then regressed, or sometimes seemed not to grow at all. Mice in which tumor grafts had regressed, or had apparently failed to grow at all, proved to be resistant on subsequent inoculation with the same tumor and sometimes to other tumors as well.
Particularly important was the evidence that successful tumor transplantation could be prevented by prior treatment of the host with grafts of normal tissues, such as those derived from embryos, or blood.
The important principles that gained recogni- II tion from this tremendous output of work, carried unwittingly using tumors, in not always the most out under the banner of cancer research, were that effective manner, to study transplantation (15) .
tumor graft regression, and the prevention of tumor graft acceptance by prior treatment with As Woglom (18) put it "the tumor problem. living cells-normal or malignant-was an im-. . munological phenomenon-the immunity involved was a tissue problem, resistance being directed being directed against tissue foreign to the body, against the tumor graft as a sfrange tissue merely, whether it was of normal or malignant origin, and not connected with any neoplastie qualities there being no qualitative differences. Nearly all . the early workers who believed that they were which the graft happened to possess using transplantation to study cancer were in fact
Only recently and by means of specially sen- The early evidence of the importance of the "race" of the host in determining the outcome of tumor transplantation in mice provided the clue that homograft incompatibility is genetically determined. Little's classic investigations on the genetics of tumor transplantation in the mouse, followed by those of Gorer and Snell and others, have brought to light the existence of a battery of at least 15 multiple allelic systems of histocompatibility genes, (analogous to the blood group factors in man) which are the genetic determinants of the cellular isoantigenic specificitics that provoke sensitivity to homografts.
Other workers have extended the validity of these findings to normal tissues (there is no evidence of any tissue or organ specificity in transplantation immunology), and to a few other species, including rats, guinea pigs, chickens, hamsters and platyfish (see 15, 20, 22) . On the basis of these animal experiments, supplemented by the results of restricted studies on exchanged skin grafts in man, we can only guess at the complexity of the genetics of tissue transplantation in the latter species.
An important pre-requisite for these genetic studies carried out in animals were different genetically uniform or isogenic strains. What a tragedy it is that even today we still find many investigators in transplantation immunology either unnecessarily complicating their projects or, not infrequently, vitiating them entirely, by failure to employ isogenic strains! Unfortunately, the largest species of mammal of which such strains are presently available is the guinea pig.
Despite the awareness of a few early investigators that tumor homograft regression is an immunological phenomenon, progress in this young and scarcely recognized branch of admunology was greatly handicapped for several decades by inability to reveal the formation of huinoral isoantibodics in response to homografts or to transfer sensitivity to normal hosts. Another obstacle was the fact that complete disintegration of cells invariably resulted in disappearance of their sensitizing properties (20) .
It was the classic work of Gorer, from 1938 onwards, and of other investigators, which established that the isoantigens determined by at least some important histocompatibility genes in mice and other species provoke the formation of scrologically detectable antibodies (23, 24) . This furnished further evidence, if any was required, that homograft reactivity is an immunological phenomenon. Early hopes that these antibodies would prove to be the mediators of homograft destruction in general have not been sustained. Only in the case of leukotic tumors, and certain solid or dissociated cellular homografts transplanted under special circumstances, has convincing evidence been forthcoming of their susceptibility to these antibodies in vivo (24) . Indeed, it has long been known that the presence of these antibodies may actually interfere with the primary sensitization of hosts confronted with solid tissue homografts-the basis of the phenomenon of immunological "enhancement" (25) .
The important principle that homograft sensitivity is transferable by means of living lymphoid cells, and that the principal seats of reactivity against solid tissue homografts are the regional lymph nodes were not discovered until 1954 by Mitchison (26, see also 20 and 22) . This finding dispelled any tendency to consider that homograft reactivity might be an immunological phenomenon sui generis, for transferability by living cells of the lymphoid series, but not by putatively immune serum, is one of the cardinal characteristics of hypersensitivity reactions of the "delayed" type, including sensitivities or allergies to drugs, micro-organisms and autoantigenic constituents of the body.
Further work along numerous lines has greatly strengthened this concept of the close affinity of homograft reactivity to delayed allergies (22) .
It has recently been shown that small lymphocytes circulating in the blood stream are just as capable of transferring homograft sensitivity passively (more correctly, adoptively) as regional node cells (27) . This may be said to complete the chain of circumstantial evidence in favor of the view that the homograft reaction is put into effect by the infiltration of a homograft by small immunologically "activated" lymphocytes produced predominantly in the regional nodes, in the case of solid tissue homografts, and transported by the blood stream.
Although the idea, that the infiltrating mono- If immunologically "activated" lymphocytes are the vehicles by means of which homograft hypersensitivity is put into effect, there is little to suggest how they damage target cells. Do they release nonspecific, highly potent pharmacologically active substances in the vicinity of target cells, as a consequence of an immunologically activated trigger mechanism? Do they transport It now appears that the antigenic specificities are associated with lipoproteins located in the microsomal fraction of homogenized cells (22) . In what physical form these substances actually escape from grafted tissues and organs (and presumably they are also released as a normal physiologic process from the cells of normal, intact animals) has yet to be discovered. Besides their ability to sensitize animals against homografts the extracted substances are serologieally active, facilitating their assay and detection (22) .
Of particular importance is the question whether the antigenic speeifieities determined by the various allelic series of histoeompatibility genes are associated with macromolecules of similar biochemical constitution, or whether these antigenie configurations are associated with a biochemically heterogeneous group of substances. Another question is whether, for a given determinant, the same "species" of "carrier" protein is always involved in cells of different types. Owen demonstrated that the majority of dizygotic cattle twins are red cell ehimeras, almost certainly as a consequence of a natural pre-natal ei'cehange of the precursors of hematopoietie cells, through anastomoses that usually interconnect the blood circulations of multiple embryos in this species. Evidently this early exposure to each others' cellular antigens renders dizygotic twins incapable of reacting against both the pre-natally exchanged cells, and their mitotie descendants and derivatives in later life.
In 1951, my colleagues and I (31, 32) obtained evidence that the tolerance induced by this prenatal exchange of red cell precursors also extends to skin grafts exchanged between the twins in later life. This tolerance is highly specific, for dizygotie twins will not accept homografts from any other donors.
With this information as our starting point, we carried out experiments designed to try and induce tolerance of skin homografts artificially in chickens, mice, rats and rabbits by injection of their embryos with living homologous tissue cells, and challenging them after they had grown up with skin homografts having the same isoantigenic constitution as the prenatally injected cells. These experiments were successful: exposure of embryos to foreign tissue cells of a variety of histological types induced tolerance of subsequent test skin homografts. These findings were rapid]y confirmed and extended by other workers. It was soon found that in many species, including mice, chickens, rats and dogs, that tolerance could still be induced by inoculation soon after birth, and that highly tolerant animals were cell ehimeras, as a consequence of the persistence of the perinatally inoculated cells or their descendants (32, 33, 34, 35) .
Discovery of the principle of immunological tolerance, which also applies to non-living antigens of other classes, such as heterologous serum proteins, and to certain microbial constituents, opened up an entirely new and exciting field of immunology dealing with the specific suppression of the capacity to react to an antigen as a consequence of exposure to it in early life, before the animal's immunological response machinery was functionally mature. Existing theories of the nature of the immunological response had to be re-examined and revised to take this phenomenon into consideration (34) , and new theories were propounded (36) . Particularly important among these was Eurnet's Clonal Selection Theory (37) which has proved to be a powerful stimulant of both thought and research at a fundamental level in immunology. All this work and thinking, I snould like to emphasize, was set in motion by the findings of experiments involving the transplantation of tissues and cells. At long last tissue "transplanters" and their principal "cult"--transplantation immunology-had won longoverdue acceptance by orthodox immunologists.
During die course of attempts to induce tolerance of hoinografts in very young rodents and birds, by inoculating them with viable suspensions of homologous cells, an entirely new phenomenon was encountered-a wasting disease or syndrome, usually described as "runt" disease (35, 38) . Among the more obvious signs of this condition, which may be acute or chronic and of delayed onset, are failure to grow and develop, splenomegaly, hepatomegaly, hyperplasm of lymphoid tissue in general, usually followed by atrophy of many of the lymph nodes. Sometimes there may be striking abnormalities of the skin (38) . Extensive studies established that runt disease, which can be produced at will with appropriate animal strains (it requires a high degree of genetic disparity between the donor and recipient strains) when homologous lymphoid cells from adult donors are inoculated into immunologically immature hosts, is immunological in origin. It is the outcome of a reaction on the part of mature, immunologically competent cells present in the inoculum, against the foreign transplantation antigens confronting them in their new hosts-i.e., it is a 'raft-versushost reaction. At present the proximate cause of death in runt disease in unknown.
Overt "small" lymphocytes) in rats (38, 40) , and on fractionated chicken blood leukocytes (41) have shown that the small lymphocyte is the immunologically competent eel! present in the blood. Another finding made with the aid of this test is that chickens' skin, but not that of mammals, appears to contain a relatively fixed population of immunologically competent cells (42) .
The initial belief that ability to become tolerant or immunologically unresponsive on exposure to antigens is the prerogative of young, relatively immature animals has proved to be incorrect.
Massive single or repeated inoculations of adult mice with homologous cells may also induce a state of unresponsiveness to homografts, closely resembling immunological tolerance in its properties (see 22) . Parabiosis (an experimental surgical procedure introduced by Sauerbruch and Heyde (43) in 1908), of genetically dissimilar rat or mouse partners may also lead to unresponsiveness to homografts. In these various procedures, where donors and recipients, or parabionts, are widely unrelated in an immunogenetic sense, the intervention of graft-versus-host reactions, closely resembling runt disease, entails a high mortality rate. This can sometimes be avoided, or minimized by appropriate genetic or other artifices.
Independent investigations along a different line, carried out at about the same time as the basic work on immunological tolerance, led to the discovery of an alternative "laboratory" solution to the homograft problem, principally applicable to mice and rats. This has provided yet another fruitful new field for transplantation studies. It turns upon the important observation that adult animals can be saved from the effects of otherwise lethal dosages of x-irradiation by giving them a "transfusion" or cellular homograft of living hematopoietic cells-prepared from infant spleen or liver, or from adult bone marrow (15, 20, 44) . These cells rapidly colonize appropriate sites in the irradiated hosts, making good the loss of the cells destroyed. Both isologous and homologous cellular grafts are effective in this respect. Homologous radiation chimeras will accept homografts of skin and other tissues having a genetic constitution similar to that of the "borrowed" hematopoietic cells upon which they are living.
An untoward complication of the employment of homologous tissue cells to rehabilitate irradiated animals was soon observed-a wasting disease sometimes referred to as "secondary radiation sickness", or "homologous disease". Analysis of this syndrome has shown that it is usually another manifestation of a graft-versushost reaction, caused in this case by the presence of immunologically competent cells in the transfused hematopoietic cell inoculum. In certain circumstances, however, homologous disease may result from recovery of immunological function on the part of the host and subsequent destruction of the borrowed hematopoietie tissue cells, leading to sickness and death through deprivation of the services of these important elements.
Each of the three principal manifestations of graft-versus-host reactivity we have considered: -runt disease, parabiosis intoxication, and the homologous disease of radiation chimeraspresents interesting problems which have been intensively investigated. Some investigators have seen in them useful models of an autoimmune disease (45) in the sense that, despite their foreign origin, the cells responsible for mounting the immunological attack are both anatomically and functionally part of the host's own. body. There certainly remains considerable scope for further studies on the immunopathology of these conditions and for further exploration of possible means of preventing or curing them (46, 47) without negating the desired influence of the inoculated cellular homografts.
The Clinical Application of Homografts
Stimulated by the results of successful experiments in mice, attempts have been made to treat leukemia in man by exposure to relatively high dosages of whole body irradiation, followed by marrow transfusion from a donor, preferably an identical twin when available, to make good the destruction of the host's hematopoietic system (44) . However, neither the irradiation, nor the graft-versus-host reaction where homolgous marrow was employed, have succeeded in eradicating all the malignant cells from the patients, as evidenced by the recurrence of the disease.
Homologous bone marrow "cellular" homografts were apparently responsible for the recovery of a few victims of radiation accidents, such as that which took place in a nuclear reactor in Yugoslavia in 1959. The grafted cells and their descendants presumably "tided" the hosts over until their own hematopoietic tissues had recovered. No one has yet succeeded in producing permanent red cell chimerism in man by marrow transfusion following irradiation or administration of radiomimetie drugs.
Though not always recognized as such, blood transfusion undoubtedly constitutes a widely employed and highly successful "cellular" homografting procedure. Of course only the erythrocytes are important here and the longevity of these cells after transfusion into compatible homologous hosts depends upon the fact that they do not manifest histocompatibility gene products in a form that sensitizes their hosts. Furthermore, in man, as in the rabbit, there is something peculiar about the intravenous route -it is not an effective route so far as the capacity of certain types of "cellular" homografts, including leukocytes, to sensitize against subsequent tissue homografts is concerned (48, 49) .
The success attending the use of eorneal homografts by ophthalmic surgeons almost certainly turns upon immunologically distinctive features of the host's cornea as a recipient area. Like the hamster's cheek pouch and the brain, it is an immunologically privileged site-i.e., one in which homografts either fail to elicit a response, or are exempt from ita consequences, because. of a break in either the afferent or the efferent pathways of the immunological reflex (1, 50, 51).
Other types of homograft which are fairly widely employed, such as bone or cartilage, owe their success to the fact that continued or even initial viability on their part is not essential for them to fulfill a clinically useful role-they simply provide matrices which are repopulated by host cells, rather like homologous blood vessel grafts and their successors, synthetic fiber "tubes" (2, 4) . However, in live cartilage homografts the cells live in a physiologically protected environment, invulnerable even to a state of pre-existing sensitivity (52) . Despite their short life expectancy skin homografts are still used as a sort of "natural" physiological dressing in cases of extensive full thickness skin loss caused by burning, etc. They may tide the patient over until definitive repair can be effected by means of skin autografts (6).
Although there is no reason to doubt that transplantation of lungs, livers, and probably even hearts, is now technically feasible in man (see 2), the emphasis of interest and activity is principally upon the kidney at present, on account of the incidence of renal diseases in young people and the fact that nearly everyone can dispense with one of these organs without incurring a serious handicap.
Irradiation, and an ever increasing diverse panel of drugs, including cortisone, 6-mercaptopurine, methotrexate or amethopterin, and Actinomysin C, are known to be capable of exerting a more or less nonspecific depressant effect upon the ability of the immunological response machinery to react against various types of antigen, including homografts. Encouraged by the successes attending renal transplantation between identical twins on the one hand, and by some more or less empirically arrived at successes in prolonging the lives of functional renal homografts in dogs by means of some of these immuno-depressant agents, singly or in combination, on the other, surgeons are now performing renal homografts in man at many centers throughout the world (53, 54, 55) . All the findings indicate that this "jumping the gun" has been attended by much more favorable results than could have been predicted from studies on skin homografts in laboratory animals. Indeed, there are some grounds for belief that it may be easier to enforce acceptance of renal homografts than those of skin. There are now several human beings who have been fortunate enough to have lived on "borrowed" donor kidneys for upwards of a year and, at the time of writing, quite a few who have had more than 6 months good use out of their renal homografts.
Here we have the unusual situation of more or less successful empirical "experiments" being conducted upon manhimself, in the full knowledge that resort will have to be made to experimental animals to rationalize them. Everyone is fully aware that renal homotransplantation, as a therapeutic procedure, is still in its infancy and that present diverse measures of obtaining success are empirical and unpredictable in their efficacy. However, in the light of accomplishments to date, one can no longer entertain any doubts that clinical solution of the organ homograft problem will soon be attained, conceivably before the skin homograft problem is solved. However, it must be pointed out that solution of the homograft problem may not provide the final answer to renal or other organ diseases. Extension of the original disease into the grafted organ is a possibility that must always be borne in mind.
From the immunological standpoint, there are good grounds for belief that during drug-or otherwise-enforced acceptance of a renal homograft upon a host, its own antigenic output, presumably released directly into the host's blood stream, may gradually and specifically weaken his ability to react against it, through the induction of transplantation tolerance.
Some of Medawar's (56) There is, in theory, a method of minimizing the immunological problem to be overcome in clinical homotransplantation, thereby greatly facilitating its solution by the sort of treatments outlined above. This entails being able to select donors in such a way as to avoid major histoincompatibility situations. At present it seems unduly optimistic to anticipate the discovery of means of "typing" individuals with respect to their histocompatibility antigens within the near future. Even if this could be done, it's extremely unlikely that completely histocompatible donors could be found for many patients needing renal or other homografts-the number of isoantigenic combinatorial possibilities is almost certainly much too great. Moreover, not everyone would be prepared to accept the risks entailed in giving up one of his kidneys for the sake of an unknown recipient, even if it would be immunologically acceptable.
As a useful interim measure, it should not be too difficult to devise a satisfactory method for selecting for a given patient, the most compatible graft donor from a small panel of volunteers, preferably drawn from his consanguineous relatives. Considerable effort is being directed towards this end (57) . Especially encouraging results have been obtained by Brent and Medawar (58) in experiments conducted in guinea pigs. They have developed a simple cutaneous test involving intradermal inoculation of potential donors with suspensions of the recipient's small lymphocytes. Essentially, this measures the intensity with which the host's immunologically competent cells can react against the transplantation antigens of the various possible donors.
Although outside the scope of this address, the storage of tissues or organs for grafting purposes still presents important unsolved problems, though the principle that mammalian cells will survive for several years at very low temperatures has been firmly established for several tissues, including skin, and for spermatozoa (59, 60) . Naturally one's thoughts go to the cadaver as providing the ideal solution to the donor problem, hut unfortunately attempts to use fresh cadaver renal homografts have not given very encouraging results. Furthermore, cadavers are likely to prove difficult subjects for matching tests. The situation may be even more complex in birds than in mammals, for in chickens there may be two different seats of lymphoid cell primordia (or lymphoid cell controlling factors):
-the thymus and the Bursa of Fabricius, a diverticulum of the cloaca. Apparently the two descendant, or "influenced", lymphoid cell populations differ in their immunological function, the thymus being the source of the cells responsible for homograft reactivity (64).
THE MAMMALIAN FETUS QUA HOMOGRAFT
Every living mammal in a non-inbred population may be said to represent a naturally successful hornograft in the sense that it was once "parabiotically" united to its mother, towards which it was potentially antigenic in respect of the transplantation antigens it inherited from its father and which the mother lacked. This almost consistent and anomalous success of fetuses as homografts has long challenged the ingenuity of transplantation immunologists who have put forward various hypotheses to account for it (22) . Everyone was in agreement that the complete separation of the maternal and fetal blood circulations is the most important factor here, preventing any appreciable exchange of cells.
However, one cannot escape the fact that maternal and fetal tissues are in intimate contact. Simmons and Russell (65) have recently shown that the trophoblast, which constitutes an uninterrupted boundary of fetal tissue in intimate contact with maternal tissue, primarily blood, consists of cells that either lack transplantation antigens or fail to express them. Thus it seems to provide a perfect immuno]ogical insulation, being both incapable of provoking maternal sensitization and insusceptible to an existing state of sensitization.
TRANSPLANTATION IN RESEARCH ON SKIN
So far, little use has been made of skin transplantation to study the etiology or principles underlying diseases or abnormalities of the integument in man, or its untoward response on exposure to contact allergens. The pioneer in this area was Haxthausen (66) , who in 1947 reciprocally exchanged autografts between areas of normal and affected skin in cases of scleroderma, vitiligo and acrodermatitis atrophicans. This work indicated the predominant influence of "local trophic influences" in these conditions. In lentigo, by contrast, no such influence was demonstrable. Long (67) has recently used this approach to study psoriasis.
In a study of considerable importance to both dermatologists and immunologists Haxthausen ingeniously side-stepped the severe restriction imposed by the homograft reaction, by employing identical twins, which as Bauer (68) had shown in 1927, will permanently accept grafts of each others' skin, as genetical theory predicted. He demonstrated (69) that skin transplanted from a normal individual to his twin, previously sensitized to a simple chemical allergen-dinitrochlorobenzene-gave a positive reaction on challenge with this allergen. However, skin from a sensitized subject grafted onto his normal twin did not respond when challenged with this agent, indicating that delayed hypersensitivity to this allergen is not tissue hound.
In another study this investigator showed that the time restriction imposed by the homograft reaction does not entirely exclude the judicious use of orthotopic skin homografts for investigating delayed allergies in man (70) . He found that skin homografts from normal subjects can manifest their new host's sensitivities as soon as they have acquired a blood supply-ic., from about the third day onwards.
Obviously, for a variety of purposes, it would be extremely useful if small grafts of human skin could be made to outlive their orthotopic transplantation to a convenient experimental animal for an experimentally worthwhile period. Unfortunately, since hetcrotran.s plantation (or Zoografting) is involved here, I feel very pessimistic whether this will ever be a practical possibility. All that can be done, at present, is to take advantage of the immunologically privileged site afforded by the sub-epithelial connective tissue of the Syrian hamster's cheek pouch (administration of cortisone to the host helps to prolong the lives of such grafts here), or the immunological immaturity of newborn rats or chick embryos (1, 51) . The "dropped" chorioallantoic membranes of 8-10 day old chick embryos will vascularize and sustain a skin heterograft in a reasonably normal condition for about 9 days.
Many problems concerned with the biology of skin can best be undertaken in experimental animals, where, by the use of autografts, or isografts exchanged between members of isogenic strains, the investigator is enabled to free himself entirely of immunological obstacles. There are several important problems of skin biology where tissue transplantation has already played, or may be expected to play, an indispensible role :-a) In the elucidation of the embryological origin of melanocytes, and the genetic control of the functional activity of these cells (71, 72) . By appropriate experimental artifices, melanocytes of one genetic constitution have been "introduced" into follicles of another, enabling the influence of the follicular milieu on the melanogenie activity of the pigment cell to be studied. b) In demonstrating that the phenomenon of pigment spread in guinea pigs' skin (71), so far as encroachment of black epidermal pigmentation into white skin areas is concerned, is the result of melanocyte migration from the pigmented areas into the amelanotic areas (73) . I feel optimistic that transplantation procedures may yet prove decisive in resolving the question of the relationship of the "cell of Langerhans" to the melanocyte. c) In the elucidation of the origin and conservation of regionally distinctive anatomical variants of the cutaneous system (74) . By studying composite grafts, in which the isolated epidermis of one type of skin has been re-associated with the denuded papillary layer of the dermis of another, it should be possible to settle, once and for all: i) Whether there are intrinsic differences between, say, the basal layer cells of the epidermis of the general integument, and cells that constitute the germinal matrix of the hair follicle, or the onychogenic epithelium that produces our finger nails, or ii) Whether the dermis in every case furnishes the structural "code", or iii) \%Thether the distinctive type of epidermis produced results from dermo-epidermal exchanges and interactions. This approach would supplement existing studies of Sengel and others conducted in eitro, using a similar principle. d) In investigating the factors responsible for the cyclical de novo formation of new skin, complete with pilosebaceous units, in the "velvet" which covers the growing antlers of deer (75, 76) .
e) In elucidating the mechanism underlying the passage of cyclical waves of hair growth activity in a symmetrical manner over the integument of certain rodents (77) .
It is interesting to note that one of the earliest applications of grafting to study the pilary system simply involved the excision of a free skin graft from a mouse's trunk and its re-implantation in the original donor site, with reversed orientation. The regenerated hairs maintained their original direction of slope, which is therefore an intrinsically determined attribute. This experiment was carried out by Schone at the beginning of this century (see 78).
TRANSPLANTATION AND AGEING
The ill-founded belief that testicular grafts could ameliorate some of the adverse effects of old age was fairly widespread at the beginning of this century and there was certainly no shortage of clinical reports to sustain it. Best known THE JOIJENAL OF INVESTIGATIVE DERMATOLOGY among the "testicular rejuvanists" was Voronoff, who encouraged the belief that heterografts from apes to men could succeed. Now, as we are regretfully aware, this work (another form of zoografting) has been thoroughly discredited. It has been well established that even homografts of endocrine tissues are, at best, only slightly less exacting in their immunological requirements for survival than skin (79, 1) . It is just worth mentioning that a few homologous or heterologous tissue cell therapists still flourish in Europe (80) , the inadequacy of the rationale of their medication apparently being made good in most cases by the faith and eminence of some of their recent "victims".
Krohn (81) has recently shown that transplantation affords an important analytic procedure in gerontology for revealing whether certain organs of the body age according to intrinsically determined programs, or according to a centrally determined control system. This procedure is applicable to tissues that can be transplanted and to species in which transplantation immunity can be circumvented. It requires the production of age chimeras (or heterochronic chimeras), bearing a functional organ or tissue graft that is chronologically much older or much younger than the host. Krohn's studies on orthotopic ovarian transplants in inbred strains of mice have shown that deficiencies in this organ are not primarily responsible for the discontinuation of its reproductive function, though they can be the reason for cessation of hormone production.
I'm sure all of us have contemplated the atrophic, inelastic, inert-looking skin about the jowls and other regions of some old gentlemen, and wondered whether it could ever be persuaded to regain its initial properties. Krohn addressed himself to this sort of question in mice, studying grafts of old skin placed upon young hosts, and skin grafts maintained for very long periods by serial propagation from one mouse to another. His provisional conclusions are :-a) that although skin maintained by grafting has a much longer life span than a mouse, it does eventually attain an age at which progressive degenerative changes appear, such as contraction, loss of fur and ultimate disintegration. Placement of such degenerating skin upon a young host does not result in its rejuvenation. It is as if the skin has a finite life-span, however it is maintained. The possibility that these degenerative changes may be due to trauma, associated with repeated grafting or other non-specific factors, cannot at present be excluded. Experiments to evaluate these possibilities are in progress.
TRANSPLANTATION IN EMBRYOLOGY AND ENOOCRTNOLOGY
Two important subjects in which tissue transplantation has played an indispensible role are Experimental Embryology and Endocrinology.
In the former, grafting experiments have made classic contributions to our understanding of determination, self-differentiation and embryonic induction (82, 83) .
In endocrinology, transplantation furnishes one of the important defining criteria of the endocrine function of a tissue-it must be possible to restore the effects of extirpation of a presumed endocrine tissue by replacing it in the host in an anatomically abnormal site. More recently transplantation has become a standard technic to elucidate a wide variety of endocrine mechanisms and interrelationships (79) .
John Hunter was certainly one of the pioneers in endocrine tissue transplantation, since he transplanted gonads in chickens in 1771. However, it was Berthold (84) who made the classical demonstration of the endocrine function of a gland-the testis-by extirpation and transplantation in cockerels in 1849.
Although there was once a phase during which transplantation of endocrine tissue was used as a rather unsatisfactory form of therapy for certain hormonal deficiencies, this has long been discontinued as extracted or synthetic hormones have become available. However, if a relatively simple procedure can be devised for overcoming the homograft reaction, then we can confidently anticipate a renewal of interest in the surgical replacement of endocrine organs.
It is worth mentioning that fairly convincing claims are still being made that transplantation of homografts, or even heterografts, of parathyroid tissue sometimes has a lasting beneficial influence in cases of hypoparathyroidism (85) . Survival of these grafts for more than a very short time can certainly be discounted as a contributory factor here. 9 . CONCLUSIONS From this rather cursory and by no means complete survey of the highly diverse fields of research activity encompassed by the term "transplantation", it is obvious that the one which currently predominates, in terms of the effort and interest it commands, is that concerned with the immunology of transplantation.
What is the particular appeal of tissue transplantation to an investigator? One's research interests, like hobbies (to some extent these are synonymous or should be) are highly individual and usually difficult to rationalize or justify. Unfortunately we sometimes have to do this when applying for grants and fellowships and immediately become aware that to tell the truth might be dangerous. For pigment cell workers the bizarre forms which melanocytes assume is usually a never-ending source of attraction and pleasure. As an experimental skin grafter, I
always derive an indefinable sense of satisfaction from the sight of a well-healed graft of my own execution, forgetting that Nature deserves most of the credit. This satisfaction is heightened if acceptance of the graft has been enforced upon a potentially resistant host by an experimental artifice. One looks at various problems of experimental biology or medicine with a one-track mind-can they be formulated in such a way that they can be solved by some sort of grafting procedure?
The generosity of my hosts on this very special occasion is such that I shall make no attempt to deceive them. I have always been a clandestine subscriber to the principle of serendipity in research (for the same reason, perhaps, I do not disbelieve in the existence in ghosts) being prepared to carry out an experiment if I felt that it was worth doing, even if I couldn't rationalize it. The proof of the pudding is always in the eating.
Many years ago I remember telling a distinguished authority of my intention to "see what would happen if I injected a suspension of living, homologous epidermal cells intravenously into adult rabbits". The idea met with a rather cold reception; my mentor reminded me that the intravenous route in this species is a very ineffective one from the viewpoint of sensitization with leucocytes. Undaunted, but clandestinely, I went ahead. I found that the information I'd been given was perfectly correct so far as it went. Neither epidermal cells nor leukocytes injected intravenously sensitized the rabbits in respect of subsequent skin homografts. Indeed, in many cases they did exactly the opposite, abrogating the hosts' capacity to reject homografts to an extent that doubled or even trebled their "life expectancy" (48)-presumably as a consequence of the induction of some form of transplantation tolerance.
On another occasion I suggested that since all domestic Syrian hamsters have originated from three litter-mates captured in Syria in 1930, they should have attained genetic uniformity by now, through close consanguineous matings. Acceptance of exchanged skin grafts should therefore be the rule rather than the exception. This time I foolishly desisted from putting the matter to the test when my genetic reasoning was quite justifiably dismissed as unsound. Nevertheless, it was later discovered independently by Adams in Boston, and by Hildemann and me in London, that hamsters are indeed anomalously hospitable towards skin homografts (86, 87) .
The moral of these anecdotes is obvious. It is not always expedient to consult one's peers about the merits of a projected experiment:
rather, seek their advice on interpretation of the findings. However, if you follow your heart in carrying out an experiment and it yields interesting results, it may lead to some embarrasment when you try and write the "Introduction" to your paper. How many people really tell the truth when describing what led them to undertake a particular piece of research? Why did John Hunter really graft the spur from a cockerel's leg onto its comb? What led SchOne to graft the entire dorsal integumentary skin from a newborn mouse onto its mother's back (see 77)? Certainly the results of these two experiments were exceedingly interesting. However, I do not wish to appear to be giving irresponsible advice to would-be transplanters.
Research in transplantation requires some apprenticeship. Woglom (18) wrote in 1929 that ". . . cancer research is a discipline requiring some apprenticeship and not everyone with an inoculating needle and a dozen white mice can plunge in and make a discovery". A similar caution is still justified in the light of many of the abundant publications appearing under the heading of transplantation immunology. For example, many people are still rushing into skin homograft work before they have studied the literature, properly mastered the technics of skin grafting, learned to avoid the pitfalls afforded by "active" skin, etc., or how to appraise the fate of their grafts properly.
I have been very lucky. I entered the transplantation field in 1946, as a student of Dr.
